Click the icons below to search through Pioneer’s reports and documents.
|Date added||April 7, 2016|
|Category||Health Care, Health Care Policy (MA), Life Sciences, White Papers|
Date: April 2016
Co-authors: Jim Stergios & Greg Sullivan
This report illustrates that state policy and legislative recommendations requiring pharmaceutical companies to disclose proprietary information would discourage the development of new innovative medicines, lead to higher healthcare costs over the long term, and potentially damage a big driver of Massachusetts’ business economy.